Business Wire

NY-O-RAN-ALLIANCE-E.V.

19.12.2019 11:59:04 CET | Business Wire | Press release

Share
O-RAN Alliance Conducts First Global Plugfest to Foster Adoption of Open and Interoperable 5G Radio Access Networks

The O-RAN Alliance successfully conducted its first worldwide plugfest and proof of concept to demonstrate the functionality as well as the multi-vendor interoperability of network equipment that complies with the recently published O1, A1, and Open Fronthaul interface specifications.

“O-RAN’s first global plugfest showcases the power of the community to document and develop truly open interface specifications with the potential to accelerate new 5G advanced services that will be multi-operator, multi-vendor, and create opportunities for the entire ecosystem,” said Andre Fuetsch, Chairman of the O-RAN Alliance and Chief Technology Officer of AT&T. “These live demonstrations represent yet another step toward the realization of O-RAN compliant 5G RAN solutions that should soon become part of the product offerings of both mainstream and niche vendors.”

ASIA

Hosted by China Mobile, the plugfest Asian Session was held in the China Mobile International Information Port, an Open Test and Integration Center, with physical attendance well over 200 attendees from over 70 companies, plus on-line attendance of over 70 participants. Representatives from global operators including British Telecom, China Telecom, China Unicom, NTT DOCOMO, Orange, Reliance Jio, Telecom Italia Mobile and an operator from North America have actively participated in this event. The plugfest tested and integrated multi-vendor solutions that comply with the O-RAN Open Fronthaul interface and exercised decoupling different hardware technologies from the RAN software:

  1. Cloud-based small cell running on virtualization technology was demonstrated by CertusNet, Lenovo, ChengDu NTS and Inventec. It features a VM-based O-CU and containerized O-DU cohosted on the same x86 processor plus accelerator platform.
  2. Multi-vendor interoperability with 5G commercial products was demonstrated by NTT DOCOMO with Fujitsu and NEC.
  3. A low power configuration of cloud base station running on Yocto OS and container technology was demonstrated by Altran, ArrayComm, WindRiver, Baicells and CIG. It features the open architecture baseband signal processing based on ARM processor plus accelerator computing platform.
  4. Soft base station with O-RAN compliant open fronthaul interface, but without virtualization, was demonstrated by Radisys, Foxconn (Taiwan), QCT and Intel. It leverages open source software including the O-RAN Open Source Community’s OFH Lib, and BBDev based Accelerator Abstraction Layer SDK API.
  5. The interworking of the O-RAN open fronthaul interface was demonstrated on technology provided by FHK (Shenzen) and Viavi, which performs comprehensive tests based on the test specification by O-RAN with O-RU and UE emulator in a multiple-UE test environment.

The plugfest held in the NTT DOCOMO R&D Center presented multi-vendor interoperability between CU/O-DU and O-RU using the O-RAN Open Fronthaul interface and multi-vendor interoperability between eNB and gNB using the O-RAN X2 interface. The functionality has been successfully demonstrated by NTT DOCOMO, Fujitsu, NEC, and Nokia. NTT DOCOMO has already started 5G pre-commercial service with the presented products. An Open Test and Integration Center is planned to be established in Japan.

NORTH AMERICA

The plugfest and proof-of-concept conducted within an Open Test and Integration Center candidate in North America, 5G COSMOS, which consists of vendor and university labs in the NYC metro area, was hosted by AT&T and focused primarily on the validation of the O1 and A1 interfaces:

  1. Physical Network Function (PNF) Plug and Play, a 3GPP-aligned O1 use case that provides a means for service providers to collaborate with equipment vendors to have PNFs discovered by Service Management Orchestration (SMO) via a PNF registration handler, was demonstrated by Nokia, CommScope and Ericsson. Remote SMO functions were also demonstrated with connections to labs in France and Germany.
  2. Bulk Performance Management Data Collection was demonstrated by Ericsson and Nokia.
  3. O1 interface functionality for Configuration, Performance, and Fault Management of multi-vendor equipment via a vendor-agnostic SMO was demonstrated by Altiostar, CommScope, and Samsung.
  4. A1 interface functionality to optimize PCI/RSI for a large-scale RAN simulator using a closed loop automation framework was demonstrated by IBM, Tech Mahindra, Wipro and highstreet technologies.
  5. Convergence of the Open Fronthaul Management Plane specification with O1 interface was demonstrated by Samsung.

“The O-RAN Alliance has been continuously expanding its influence in the industry since its inception. It is really amazing to see such a symbolic milestone achieved just 10 months since its release of the first specification in MWC Barcelona this year,” said Zhengmao Li, EVP of China Mobile. “The successful holding of the plugfest event globally with deep contribution from over 30 partners represents a consolidated step towards a full disaggregated O-RAN compliant 5G network.”

Dr. Hiroshi Nakamura, EVP and CTO, NTT DOCOMO commented, "We believe wide adoption of O-RAN compliant products will enable more agile, flexible and cost-effective network construction, and welcome the testing and integration efforts of O-RAN standards that are being carried out across the globe. NTT DOCOMO will continue to lead O-RAN Alliance activities and expand its 5G network, and will accelerate the co-creation of 5G services and markets with vertical industry partners."

O-RAN Industry Briefing at MWC 2020

For a comprehensive update on O-RAN activities, including significant developments in Europe, the O-RAN community will come together for the O-RAN Industry Briefing event at MWC Barcelona 2020. Representatives from O-RAN operator and vendor member organizations will discuss and share views on the important steps towards realizing O-RAN compliant commercial solutions. O-RAN Alliance is looking forward to meeting you on Feb 25, 2020, 9:30-10:30 am at the Deutsche Telekom Booth, Hall 3, Booth 3M31.

About O-RAN Alliance

O-RAN Alliance is a world-wide community of more than 130 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, O-RAN Alliance’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN-compliant mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, O-RAN Alliance publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.

For more information please visit www.o-ran.org .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye